No new digest content identified.
National Health Commission of the People’s Republic of China
Nov 7: Daily briefing on novel coronavirus cases in China
On Nov 6, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 33 new cases of confirmed infections.
Chinese vice premier demands efforts to curb epidemic spread
Updated: 2020-11-06 | Xinhua
KASHGAR — Chinese Vice Premier Sun Chunlan has stressed a science-based and targeted approach, as well as resolute measures to curb the spread of the COVID-19 epidemic in northwest China’s Xinjiang Uygur Autonomous Region to safeguard the lives and health of people of all ethnic groups.
Sun made the remarks during her visit to Kashgar and Kirgiz Autonomous Prefecture of Kizilsu in southern Xinjiang on Wednesday and Thursday.
The cluster cases in Kashgar were discovered at an early stage, Sun said, adding that with a timely emergency response mechanism and decisive measures, major progress was achieved in containing the outbreak, and the epidemic situation is on the whole manageable…
One more Chinese COVID-19 vaccine ready for phase-3 clinical trials
Updated: 2020-11-02 | Xinhua
BEIJING — A COVID-19 vaccine candidate developed by the Institute of Microbiology under the Chinese Academy of Sciences has shown to be safe in early-stage trials, suggesting potential for further clinical tests.
The results of phase-1 and phase-2 trials support the safety and immunogenicity of this recombinant subunit vaccine in healthy participants, and no serious adverse events have been found so far, the institute said in a statement on Oct 30.
Jointly developed by the institute and Chongqing Zhifei Biological Products Co Ltd, the vaccine was issued with a clinical research permit from the National Medical Products Administration on June 19…